secwatch / observer
8-K filed March 30, 2026, 7:59 PM ET CIK 0001733443
other material confidence high sentiment neutral materiality 0.80

5&2 Studios stockholders approve 1-for-173,750 reverse split; cash for fractional shares at $3.75

5&2 Studios, Inc.

item 5.03item 5.07item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001104659-26-036919
form_type
8-K
ticker
null
cik
0001733443
company_name
5&2 Studios, Inc.
filed_at
2026-03-30T23:59:59+00:00
discovered_at
2026-05-14T18:02:36.028481+00:00
generated_at
2026-05-15T08:24:36.853140+00:00
sec_items
["5.03", "5.07", "9.01"]
event_type
other_material
sentiment
neutral
materiality_score
0.8
calibrated_materiality_score
0.8
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001104659-26-036919
json_url
https://secwatch.observer/filing/0001104659-26-036919.json
markdown_url
https://secwatch.observer/filing/0001104659-26-036919.md
text_url
https://secwatch.observer/filing/0001104659-26-036919.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1733443/000110465926036919/0001104659-26-036919-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1733443/000110465926036919/tm2610568d1_8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

9d14c6ef7adea6ea8873b5ae65ece981b354bcc1

5&2 Studios, Inc.: Amendment to Certificate of Incorporation to effect a 1-for-173,750 reverse stock split of Common Stock (effective 2025-12-31).

On December 31, 2025, the Board of Directors (the "Board") of 5&2 Studios, Inc. (the "Company") approved an amendment to the Company's Certificate of Incorporation (the "Amendment") to change the number of issued and outstanding shares of Series A common stock, par value $0.001 per share (the "Series A Common Stock"), and Series B common stock, par value $0.001 per share (the "Series B Common Stock" and, together with the Series A Common Stock, the "Common Stock"), of the Company, by effecting a 1-for-173,750 reverse stock split (the "Reverse Stock Split"), as a result of which stockholders of record will receive a cash payment of $3.75 per pre-Reverse Stock Split share in lieu of receiving a fractional post-Reverse Stock Split share.

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

Comparable filings

SLXN

Silexion shareholders approve 50M share increase, expanded equity plan, and 1-for-10 reverse split

Silexion Therapeutics Corp May 5, 2026, 7:59 PM ET other_material Items 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

On December 31, 2025, the Board of Directors (the "Board") of 5&2 Studios, Inc. (the "Company") approved an amendment to the Company's Certificate of Incorporation (the "Amendment") to change the number of issued and outstanding shares of Series A common stock, par value $0.001 per share (the "Series A Common Stock"), and Series B common stock, par value $0.001 per share (the "Series B Common Stock" and, together with the Series A Common Stock, the "Common Stock"), of the Company, by effecting a 1-for-173,750 reverse stock split (the "Reverse Stock Split"), as a result of which stockholders of record will receive a cash payment of $3.75 per pre-Reverse Stock Split share in lieu of receiving a fractional post-Reverse Stock Split share.

Comparable filing

At the extraordinary general meeting of Silexion Therapeutics Corp (the “ Company ”) originally held on April 28, 2026 and reconvened on May 5, 2026 (the “ Meeting ”), the shareholders of the Company duly approved a resolution serving as an effective amendment to paragraph 5 of the Company’s amended and restated memorandum of association (the “ Memorandum Amendment”) , which increased the Company’s authorized share capital, as described in Item 5.07 below.

Filing page SEC filing

MRKR

Marker Therapeutics shareholders approve increase in authorized shares from 30M to 130M

Marker Therapeutics, Inc. May 4, 2026, 7:59 PM ET other_material Items 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

On December 31, 2025, the Board of Directors (the "Board") of 5&2 Studios, Inc. (the "Company") approved an amendment to the Company's Certificate of Incorporation (the "Amendment") to change the number of issued and outstanding shares of Series A common stock, par value $0.001 per share (the "Series A Common Stock"), and Series B common stock, par value $0.001 per share (the "Series B Common Stock" and, together with the Series A Common Stock, the "Common Stock"), of the Company, by effecting a 1-for-173,750 reverse stock split (the "Reverse Stock Split"), as a result of which stockholders of record will receive a cash payment of $3.75 per pre-Reverse Stock Split share in lieu of receiving a fractional post-Reverse Stock Split share.

Comparable filing

the Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation, as amended, to increase the number of authorized shares of our Common Stock from 30,000,000 shares of Common Stock to 130,000,000 shares of Common Stock (the “ Charter Amendment ”).

Filing page SEC filing

CWEN

Clearway Energy eliminates Class A stock; converts all shares to reduced-vote Class C

Clearway Energy, Inc. May 1, 2026, 7:59 PM ET other_material Items 1.01, 3.03, 5.03, 5.07, 7.01, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

On December 31, 2025, the Board of Directors (the "Board") of 5&2 Studios, Inc. (the "Company") approved an amendment to the Company's Certificate of Incorporation (the "Amendment") to change the number of issued and outstanding shares of Series A common stock, par value $0.001 per share (the "Series A Common Stock"), and Series B common stock, par value $0.001 per share (the "Series B Common Stock" and, together with the Series A Common Stock, the "Common Stock"), of the Company, by effecting a 1-for-173,750 reverse stock split (the "Reverse Stock Split"), as a result of which stockholders of record will receive a cash payment of $3.75 per pre-Reverse Stock Split share in lieu of receiving a fractional post-Reverse Stock Split share.

Comparable filing

Following the Class A Conversion, on May 1, 2026, the Company filed with the Delaware Secretary of State a certificate of retirement pursuant to Section 243 of the DGCL (the “Certificate of Retirement”) to retire all shares of Class A common stock converted in the Class A Conversion, which also had the effect of amending the Amended Charter to (i) reduce the total number of authorized shares of Class A common stock from 34,613,853 to zero, (ii) reduce the total number of authorized shares of capital stock of the Company from 2,544,613,853 to 2,510,000,000 and (iii) eliminate from the Amended Charter all references to the Class A common stock (collectively, the “Class A Retirement”).

Filing page SEC filing

DMAA

SPAC DMAA shareholders approve extension to April 2027; ~28% of shares redeemed for $99.3M

Drugs Made In America Acquisition Corp. May 1, 2026, 7:59 PM ET other_material Items 5.03, 5.07, 8.01, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

On December 31, 2025, the Board of Directors (the "Board") of 5&2 Studios, Inc. (the "Company") approved an amendment to the Company's Certificate of Incorporation (the "Amendment") to change the number of issued and outstanding shares of Series A common stock, par value $0.001 per share (the "Series A Common Stock"), and Series B common stock, par value $0.001 per share (the "Series B Common Stock" and, together with the Series A Common Stock, the "Common Stock"), of the Company, by effecting a 1-for-173,750 reverse stock split (the "Reverse Stock Split"), as a result of which stockholders of record will receive a cash payment of $3.75 per pre-Reverse Stock Split share in lieu of receiving a fractional post-Reverse Stock Split share.

Comparable filing

to amend the Company’s Second Amended and Restated Memorandum and Articles of Association (the “ Existing Charter ”) by adopting an amendment to the Existing Charter in the form set forth in Annex A to the Proxy Statement (the “ Extension Amendment ”) which reflects the extension of the date by which the Company must consummate a business combination (the “ Combination Period ”) up to twelve (12) times from April 29, 2026 (the “ Termination Date ”) to April 29, 2027, each by an additional one (1) month

Filing page SEC filing

LXRX

Lexicon doubles authorized shares to 900M, adopts expanded 2026 equity plans

LEXICON PHARMACEUTICALS, INC. April 30, 2026, 7:59 PM ET other_material Items 3.02, 5.02, 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

On December 31, 2025, the Board of Directors (the "Board") of 5&2 Studios, Inc. (the "Company") approved an amendment to the Company's Certificate of Incorporation (the "Amendment") to change the number of issued and outstanding shares of Series A common stock, par value $0.001 per share (the "Series A Common Stock"), and Series B common stock, par value $0.001 per share (the "Series B Common Stock" and, together with the Series A Common Stock, the "Common Stock"), of the Company, by effecting a 1-for-173,750 reverse stock split (the "Reverse Stock Split"), as a result of which stockholders of record will receive a cash payment of $3.75 per pre-Reverse Stock Split share in lieu of receiving a fractional post-Reverse Stock Split share.

Comparable filing

The Seventh Amended and Restated Certificate of Incorporation increases the number of shares of our authorized Common Stock from 450,000,000 to 900,000,000.

Filing page SEC filing

DGAC

Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE

DISCIPLINED GROWTH ACQUISITION Corp June 1, 2026, 4:15 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: governance_change same SEC item: 5.03, 9.01 same event type: other_material similar materiality

This filing

On December 31, 2025, the Board of Directors (the "Board") of 5&2 Studios, Inc. (the "Company") approved an amendment to the Company's Certificate of Incorporation (the "Amendment") to change the number of issued and outstanding shares of Series A common stock, par value $0.001 per share (the "Series A Common Stock"), and Series B common stock, par value $0.001 per share (the "Series B Common Stock" and, together with the Series A Common Stock, the "Common Stock"), of the Company, by effecting a 1-for-173,750 reverse stock split (the "Reverse Stock Split"), as a result of which stockholders of record will receive a cash payment of $3.75 per pre-Reverse Stock Split share in lieu of receiving a fractional post-Reverse Stock Split share.

Comparable filing

On May 26, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies, which was effective on May 26, 2026.

Filing page SEC filing

SAGU

Shreya Acquisition Group closes $110M IPO, 11M units at $10 each on NYSE

Shreya Acquisition Group May 11, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: governance_change same SEC item: 5.03, 9.01 same event type: other_material similar materiality

This filing

On December 31, 2025, the Board of Directors (the "Board") of 5&2 Studios, Inc. (the "Company") approved an amendment to the Company's Certificate of Incorporation (the "Amendment") to change the number of issued and outstanding shares of Series A common stock, par value $0.001 per share (the "Series A Common Stock"), and Series B common stock, par value $0.001 per share (the "Series B Common Stock" and, together with the Series A Common Stock, the "Common Stock"), of the Company, by effecting a 1-for-173,750 reverse stock split (the "Reverse Stock Split"), as a result of which stockholders of record will receive a cash payment of $3.75 per pre-Reverse Stock Split share in lieu of receiving a fractional post-Reverse Stock Split share.

Comparable filing

On May 6, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

Filing page SEC filing

SUJA

Suja Life completes IPO of 8.9M shares at $21/share; closes May 8, 2026

SUJA LIFE, INC. May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 3.03, 5.03, 5.02, 9.01

same fact type: governance_change same SEC item: 5.03, 9.01 same event type: other_material similar materiality

This filing

On December 31, 2025, the Board of Directors (the "Board") of 5&2 Studios, Inc. (the "Company") approved an amendment to the Company's Certificate of Incorporation (the "Amendment") to change the number of issued and outstanding shares of Series A common stock, par value $0.001 per share (the "Series A Common Stock"), and Series B common stock, par value $0.001 per share (the "Series B Common Stock" and, together with the Series A Common Stock, the "Common Stock"), of the Company, by effecting a 1-for-173,750 reverse stock split (the "Reverse Stock Split"), as a result of which stockholders of record will receive a cash payment of $3.75 per pre-Reverse Stock Split share in lieu of receiving a fractional post-Reverse Stock Split share.

Comparable filing

On May 7, 2026, the Company filed an amended and restated certificate of incorporation (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware

Filing page SEC filing

Source: SEC EDGAR
accession 0001104659-26-036919
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.